FDA Drops Proposal Requiring Sponsors to Report Falsified Data

International Pharmaceutical Regulatory Monitor
A A
The FDA scrapped a proposed rule that would have required drug sponsors to report possibly fabricated data in the clinical trials.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00